Investing.com -- 在这家临床阶段生物制药公司宣布计划公开发行5000万美元普通股股票后,Absci Corp (NASDAQ:ABSI)股价下跌了11.4%。 该公司专注于利用生成式人工智能设计治疗方案,表示将授予承销商30天期权,可额外购买价值750万美元的股票。此次拟议发行的所有股票将由Absci出售。 根据公告,Absci计划将所得款项用于推进其内部开发的项目,并继续投资其...
Source LinkInvesting.com -- 在这家临床阶段生物制药公司宣布计划公开发行5000万美元普通股股票后,Absci Corp (NASDAQ:ABSI)股价下跌了11.4%。 该公司专注于利用生成式人工智能设计治疗方案,表示将授予承销商30天期权,可额外购买价值750万美元的股票。此次拟议发行的所有股票将由Absci出售。 根据公告,Absci计划将所得款项用于推进其内部开发的项目,并继续投资其...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.